Literature DB >> 6980917

Functionally different T lymphocyte subpopulations determined by their sensitivity to complement-dependent cell lysis with the monoclonal antibody 4A.

Y Morishima, M Kobayashi, S Y Yang, N H Collins, M K Hoffmann, B Dupont.   

Abstract

A human T lymphocyte antigen 4A (40,000 daltons) is defined by a monoclonal, complement- (C) fixing, hybridoma-produced antibody (moAb 4A). This antigen, which is identical to the previously reported antigen 3A 1, is expressed at quantitatively different levels on functional subsets of peripheral T lymphocytes as determined by the cell sensitivity to antibody and C. Peripheral T lymphocytes can be divided into two populations: 4A high-density T cells (4A increases), which are killed in vitro by moAb 4A + C, and 4A low-density T cells (4A decreases), which are not affected in vitro by moAb 4A + C treatment. The helper/inducer T cell lineage, defined by moAb Leu 3a, and the cytotoxic/suppressor T cell lineage, defined by moAb Leu 2A, contain both 4A increases and 4A decreases T cell populations. Functional studies by moAb 4A + C treatment show that 1) the 4A increases T cell population contains T helper cells, which are necessary for in vitro antibody production against red cell-bound determinant; 2) the 4A decreases T cell population contains the precursor T cells, which proliferate in vitro in MLC, and the precursor T cells, which are necessary for the in vitro generation of the alloreactive cytotoxic T cells; and 3) the cytotoxic activity of alloreactive T cells generated in CML assay is abrogated by moAb 4A + C treatment; 4) the activation of T cells by PHA and Con A increases the quantitative expression of 4A antigen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980917

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  T cell signal transduction and the role of CD7 in costimulation.

Authors:  R Stillwell; B E Bierer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Molecular cloning of the gene coding for the human T cell differentiation antigen CD7.

Authors:  K Yoshikawa; M Seto; R Ueda; Y Obata; K Notake; T Yokochi; T Takahashi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Inhibition of lymphocyte proliferation by a monoclonal antibody (RFT2) against CD7.

Authors:  Y Costantinides; G Kingsley; C Pitzalis; G S Panayi
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

4.  Molecular cloning of the gene coding for the mouse T-cell antigen CD7.

Authors:  K Yoshikawa; M Seto; R Ueda; Y Obata; S Aoki; T Takahashi
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  IEF patterns of HLA-B13 antigens from Orientals and Caucasians.

Authors:  S Y Yang; A Chang; R Olivero; V Relias; E J Yunis
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

6.  Decreased expression of CD7 occurs in rheumatoid arthritis.

Authors:  A I Lazarovits; J Karsh
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

7.  Defective expression of T cell-associated glycoprotein in severe combined immunodeficiency.

Authors:  L K Jung; S M Fu; T Hara; N Kapoor; R A Good
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

8.  The microenvironment of coeliac disease: T cell phenotypes and expression of the T2 'T blast' antigen by small bowel lymphocytes.

Authors:  G Malizia; L K Trejdosiewicz; G M Wood; P D Howdle; G Janossy; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

9.  Lineage-related polypeptide markers in acute lymphoblastic leukemia detected by two-dimensional gel electrophoresis.

Authors:  S M Hanash; L J Baier; L McCurry; S A Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

10.  Monoclonal antibody (WT 1) directed against a T cell surface glycoprotein: characteristics and immunosuppressive activity.

Authors:  W J Tax; N Tidman; G Janossy; L Trejdosiewicz; R Willems; J Leeuwenberg; T J De Witte; P J Capel; R A Koene
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.